Ovarian Cancer Treatment & Clinical Trials - Dana-Farber Cancer Institute

Ovarian Cancer Overview

If you or a loved one has ovarian cancer, the ovarian cancer team at the Susan F. Smith Center for Women's Cancers Gynecologic Oncology Program is here to help. The internationally recognized team of experts at the Susan F. Smith Center for Women's Cancers is dedicated to providing compassionate care and personalized diagnosis, treatment, and support all of our ovarian cancer patients and their loved ones.
Exceptional Care for Patients with Ovarian Cancer — You Have...
- A team of gynecologic oncology specialists who diagnose and treat hundreds of patients with ovarian cancer each year, and who are setting treatment guidelines for other physicians around the world
- Numerous clinical trials of emerging and novel treatments for ovarian cancer, some of which may not be available elsewhere
- Genetic testing and counseling and personalized early detection strategies for women and their families who have a hereditary risk of breast and ovarian and breast cancers
- Access to world-renowned pathologists who specialize in gynecologic cancer diagnosis
- Specialized care for people with sexual health or fertility concerns, and access to a wide array of support services and survivorship care
We Treat You, Not Just Your Cancer

We offer many programs to support our patients and their loved ones before, during, and after treatment, including:
Read our Insight blog for information and inspiration about ovarian cancer treatment at Dana-Farber.

New Patient Appointments
877-442-3324
Make Appointment Online
Center for BRCA and Related Genes

Mutations in BRCA1, BRCA2, and BRCA-related genes confer increased risk of certain cancers when inherited. These mutations can also be acquired by the cancers themselves. The Center for BRCA and Related Genes provides comprehensive care for patients with inherited and acquired mutations, including clinical therapeutic trials, trials of risk-reducing strategies, and studies of novel early detection markers.
Beyond Gynecologic Cancer: Celebrating Survivorship

Women with gynecologic cancers and survivors, along with their caregivers and loved ones, gathered for a morning of education, support, and companionship.
Clinical Trials Questions?
877-DF-TRIAL
(877-338-7425)

More Information
Becoming a Patient

As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

Support Services and Amenities

We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.

Support Services brochure

Breast and Ovarian Cancer Genetics and Prevention Program

If you or your doctor thinks you are at high risk of developing breast or ovarian cancer, the Cancer Genetics and Prevention Program, led by Judy Garber, MD, MPH, will create a personalized program to estimate your risk, and work with you and your clinical team to lower your risk as much as possible.
More information on ovarian cancer
Caregiving

Coping with Cancer

COVID-19

Health & Wellness

Nutrition & Diet

Risk & Prevention

Survivorship

Teaching Sheets

Treatments & Procedures

Video
News Releases
10/8/2020
Dana-Farber/Harvard Cancer Center wins prestigious federal grant to accelerate ovarian cancer research

Research
Ovarian Cancer

Insight Blog
9/25/2020
Ovarian Cancer Patient Benefits From New Research

Patient Stories, Adult
Ovarian Cancer
Gynecologic Cancer

Insight Blog
9/9/2020
Ovarian Cancer Clinical Trial Helps Grandmother Feel Stable During a Difficult Year

Patient Stories, Adult
Ovarian Cancer
Gynecologic Cancer

News Releases
8/12/2020
Dana-Farber launches new Center for the prevention and treatment of BRCA-related cancers

BRCA
Ovarian Cancer
Gynecologic Cancer
Prostate Cancer
Pancreatic Cancer
Metastatic Breast Cancer
Breast Cancer

Publications
6/18/2020
Unexpected Benefits from Targeted Therapy

Precision Cancer Medicine
Ovarian Cancer
Breast Cancer

News Releases
6/15/2020
Drug with new approach on impeding DNA repair shows promise in first clinical trial

Precision Cancer Medicine
Ovarian Cancer

News Releases
3/19/2020
Scientists identify factors for predicting which patients with ovarian cancer won’t benefit from immunotherapy-PARP inhibitor combination

Precision Cancer Medicine
Immunotherapy
Ovarian Cancer

Insight Blog
12/2/2019
Young Investigators Use Patient Samples for Cancer Studies

Research
Ovarian Cancer
Breast Cancer

Insight Blog
9/19/2019
Basic Science Discovery Leads to Clinical Trial for Patients with Chemotherapy-Resistant Form of Ovarian Cancer

Research
Ovarian Cancer
Gynecologic Cancer

Ovarian Cancer

Ovarian Cancer Overview

Exceptional Care for Patients with Ovarian Cancer — You Have...

We Treat You, Not Just Your Cancer

More Information

More information on ovarian cancer

Dana-Farber/Harvard Cancer Center wins prestigious federal grant to accelerate ovarian cancer research

Ovarian Cancer Patient Benefits From New Research

Ovarian Cancer Clinical Trial Helps Grandmother Feel Stable During a Difficult Year

Dana-Farber launches new Center for the prevention and treatment of BRCA-related cancers

Unexpected Benefits from Targeted Therapy

Drug with new approach on impeding DNA repair shows promise in first clinical trial

Scientists identify factors for predicting which patients with ovarian cancer won’t benefit from immunotherapy-PARP inhibitor combination

Young Investigators Use Patient Samples for Cancer Studies

Basic Science Discovery Leads to Clinical Trial for Patients with Chemotherapy-Resistant Form of Ovarian Cancer